Purpose
Acne Treatment
Killa Acne Extra Strength
FDA Label NDC 81746-420
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Zitsticka, Inc. for the product Killa Acne Extra Strength (NDC 81746-420). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, ask a doctor, when using this product, keep out of reach of children, na, warnings, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Ask A Doctor
If irritation becomes severe
When Using This Product
Skin irritation and dryness may occur if you use another topical acne medication at the same time or immediately following. If irritation occurs, only use one topical acne medication at a time unless directed by a doctor.
Keep Out Of Reach Of Children
If swallowed, get medical help or contact a Posion Control Center right away.
Na
NA
Warnings
For extrernal use only
Inactive Ingredients
Inactive Ingredients:
Sodium Hyaluronate, Phytosphingosine HCL, Niacinamide, Oligopeptide-10, Glycolic Acid, Madecassoside, 4-Butylresorcinol, Centella Asiatica Extract.
Patch: Hydrocolloid
Uses
Uses:
- For the management of acne.
- Penetrates pores to eliminate most blemishes
* Please review the disclaimer below.
